Alpha-1 antitrypsin deficiency, commonly known as A1AD, is a hereditary condition that disrupts the production of a crucial protein called alpha-1 antitrypsin. This protein plays a vital role in safeguarding the body against the harmful effects of an enzyme known as neutrophil elastase. Normally, white blood cells generate this enzyme to combat infections. However, it remains harmless to healthy tissues unless the levels of alpha-1 antitrypsin are insufficient.
The tissues in the lungs and liver are particularly susceptible to damage caused by neutrophil elastase. Consequently, individuals with A1AD face a heightened risk of developing lung and liver diseases, which are the primary health concerns associated with this genetic disorder.
Complications of Alpha-1 Antitrypsin Deficiency: Lung Disease
Alpha-1 Antitrypsin Deficiency (A1AD) can lead to various complications, particularly in the lungs. Individuals with A1AD often experience symptoms of lung disease, such as shortness of breath even without physical exertion, wheezing, fatigue, unexplained weight loss, and frequent respiratory infections. Additionally, the deficiency increases the risk of developing emphysema, which is characterized by difficulty breathing, a sharp or hacking cough, and a barrel-shaped chest.
Complication: Liver Disease
A1AD can lead to liver disease in a small percentage of both infants and adults. Approximately ten percent of infants and 15 percent of adults with A1AD experience liver disease. In infants, the most common manifestation is jaundice, a condition resulting from the accumulation of bilirubin, a harmful toxin. On the other hand, adults with A1AD usually develop liver disease in the form of liver scarring or cirrhosis, which can lead to symptoms such as a swollen abdomen, feet, or legs, as well as jaundice.